These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

621 related items for PubMed ID: 27149402

  • 1. Preferences for improvements in attributes associated with basal insulin: a time trade-off and willingness-to-pay survey of a diabetic and non-diabetic population in Sweden.
    Olofsson S, Norrlid H, Persson U.
    J Med Econ; 2016 Oct; 19(10):945-58. PubMed ID: 27149402
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Willingness to pay for improvements in chronic long-acting insulin therapy in individuals with type 1 or type 2 diabetes mellitus.
    Lloyd A, Nafees B, Barnett AH, Heller S, Ploug UJ, Lammert M, Bøgelund M.
    Clin Ther; 2011 Sep; 33(9):1258-67. PubMed ID: 21862132
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Evaluation of the cost-utility of insulin degludec vs insulin glargine in Sweden.
    Ericsson Å, Pollock RF, Hunt B, Valentine WJ.
    J Med Econ; 2013 Dec; 16(12):1442-52. PubMed ID: 24147661
    [Abstract] [Full Text] [Related]

  • 7. Do utility values and willingness to pay suitably reflect health outcome in hip and knee osteoarthritis? A comparative analysis with the WOMAC Index.
    Ethgen O, Tancredi A, Lejeune E, Kvasz A, Zegels B, Reginster JY.
    J Rheumatol; 2003 Nov; 30(11):2452-9. PubMed ID: 14677192
    [Abstract] [Full Text] [Related]

  • 8. A welfare economic approach to measure outcomes in stuttering: comparing willingness to pay and quality adjusted life years.
    Franic DM, Bothe AK, Bramlett RE.
    J Fluency Disord; 2012 Dec; 37(4):300-13. PubMed ID: 23218213
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Estimating the monetary value of a Quality-Adjusted Life-Year in Quebec.
    Kouakou CRC, He J, Poder TG.
    Eur J Health Econ; 2024 Jul; 25(5):787-811. PubMed ID: 37656261
    [Abstract] [Full Text] [Related]

  • 11. A Contingent Valuation Study for Eliciting a Monetary Value of a Quality-Adjusted Life-Year in the General Greek Population.
    Mavrodi A, Aletras V.
    Value Health Reg Issues; 2020 Sep; 22():36-43. PubMed ID: 32731168
    [Abstract] [Full Text] [Related]

  • 12. Valuing injection frequency and other attributes of type 2 diabetes treatments in Australia: a discrete choice experiment.
    Fifer S, Rose J, Hamrosi KK, Swain D.
    BMC Health Serv Res; 2018 Aug 30; 18(1):675. PubMed ID: 30165844
    [Abstract] [Full Text] [Related]

  • 13. Willingness to pay for QALY: perspectives and contexts in Japan.
    Igarashi A, Goto R, Yoneyama-Hirozane M.
    J Med Econ; 2019 Oct 30; 22(10):1041-1046. PubMed ID: 31262236
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Willingness to pay for a quality-adjusted life year: implications for societal health care resource allocation.
    King JT, Tsevat J, Lave JR, Roberts MS.
    Med Decis Making; 2005 Oct 30; 25(6):667-77. PubMed ID: 16282217
    [Abstract] [Full Text] [Related]

  • 16. Willingness to pay for a QALY.
    Gyrd-Hansen D.
    Health Econ; 2003 Dec 30; 12(12):1049-60. PubMed ID: 14673813
    [Abstract] [Full Text] [Related]

  • 17. Willingness-to-pay for benefits associated with basal insulin treatment of type 2 diabetes.
    Jendle J, Ridderstråle M, Torfvitt O, Ericsson A, Larsen S.
    J Med Econ; 2012 Dec 30; 15(2):261-3. PubMed ID: 22142237
    [Abstract] [Full Text] [Related]

  • 18. Willingness to pay for a QALY: theoretical and methodological issues.
    Gyrd-Hansen D.
    Pharmacoeconomics; 2005 Dec 30; 23(5):423-32. PubMed ID: 15896094
    [Abstract] [Full Text] [Related]

  • 19. A valuation of patients' willingness-to-pay for insulin delivery in diabetes.
    Guimarães C, Marra CA, Colley L, Gill S, Simpson SH, Meneilly GS, Queiroz RH, Lynd LD.
    Int J Technol Assess Health Care; 2009 Jul 30; 25(3):359-66. PubMed ID: 19619355
    [Abstract] [Full Text] [Related]

  • 20. Willingness to pay for a quality-adjusted life-year: the individual perspective.
    Bobinac A, Van Exel NJ, Rutten FF, Brouwer WB.
    Value Health; 2010 Dec 30; 13(8):1046-55. PubMed ID: 20825620
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.